SRC
CLB icon

Shufro Rose & Co’s Core Laboratories CLB Stock Holding History

Shufro Rose & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-7,500
Closed -$350K – 320
2019
Q3 		$350K Hold
7,500
– – 0.03% 200
2019
Q2 		$392K Buy
+7,500
New +$440K 0.04% 191
2019
Q1 		– Sell
-26,062
Closed -$1.55M – 305
2018
Q4 		$1.55M Sell
26,062
-29,100
-53% -$2.51M 0.17% 90
2018
Q3 		$6.39M Sell
55,162
-7,010
-11% -$791K 0.59% 49
2018
Q2 		$7.85M Sell
62,172
-4,715
-7% -$574K 0.75% 41
2018
Q1 		$7.24M Sell
66,887
-735
-1% -$81.3K 0.71% 42
2017
Q4 		$7.41M Sell
67,622
-2,445
-3% -$244K 0.73% 41
2017
Q3 		$6.92M Sell
70,067
-3,015
-4% -$292K 0.7% 44
2017
Q2 		$7.4M Sell
73,082
-2,266
-3% -$244K 0.79% 40
2017
Q1 		$8.7M Buy
75,348
+10,287
+16% +$1.2M 0.94% 33
2016
Q4 		$7.81M Sell
65,061
-4,899
-7% -$542K 0.87% 35
2016
Q3 		$7.86M Buy
69,960
+10,405
+17% +$1.2M 0.88% 37
2016
Q2 		$7.38M Sell
59,555
-2,125
-3% -$257K 0.82% 40
2016
Q1 		$6.93M Sell
61,680
-1,245
-2% -$129K 0.77% 46
2015
Q4 		$6.84M Sell
62,925
-11,424
-15% -$1.31M 0.79% 44
2015
Q3 		$7.42M Sell
74,349
-205
-0.3% -$22.3K 0.89% 41
2015
Q2 		$8.5M Sell
74,554
-766
-1% -$92.9K 0.9% 41
2015
Q1 		$7.87M Buy
75,320
+354
+0.5% +$37.7K 0.81% 46
2014
Q4 		$9.02M Buy
74,966
+8,410
+13% +$1.1M 0.92% 34
2014
Q3 		$9.74M Buy
66,556
+11,505
+21% +$1.78M 1.01% 34
2014
Q2 		$9.2M Buy
+55,051
New +$9.79M 0.94% 36

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Shufro Rose & Co's CLB Position: Q4 2019 in Review

Shufro Rose & Co sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 7,500 shares — an estimated $350K sold.

Shufro Rose & Co first reported a position in CLB in Q2 2014 and held it in 21 quarters. The position peaked at $9.74M in Q3 2014. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • Shufro Rose & Co reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • Shufro Rose & Co sold 7,500 Core Laboratories shares in Q4 2019, an estimated $350K.
  • Shufro Rose & Co first reported a position in Core Laboratories in Q2 2014 and held it in 21 quarters.
  • Shufro Rose & Co's Core Laboratories position peaked at $9.74M in Q3 2014.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on Shufro Rose & Co's 13F filing for Q4 2019, filed 28 Jan 2020.